We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Multiple craniospinal tumors in a pediatric patient with neurofibromatosis type 2: a case report.
- Authors
Kim, Bo-Seob; Jung, Tae-Young; Jang, Woo-Youl; Baek, Hee-Jo; Kim, Seul-Kee; Lee, Kyung-Hwa
- Abstract
Introduction: Neurofibromatosis type 2 (NF-2) is an inherited disease, linked with abnormalities in the NF-2 gene, which is located on chromosome 22 and involved in merlin production. Many craniospinal tumors are common in individuals with NF-2. We present a case of NF-2 with the rapid symptomatic progression of multiple craniospinal tumors. Case report: A 12-year-old male complained of headache and hearing impairment in the right ear for 7 months. Brain magnetic resonance imaging (MRI) revealed a right frontal meningioma, bilateral vestibular and trigeminal schwannomas, and a brainstem tumor. He was diagnosed with NF-2 and underwent brain surgery and radiotherapy for chordoid meningioma. He complained of right leg motor weakness 5 months post-surgery. The spine MRI showed multiple heterogeneously enhanced masses spreading over the entire spinal cord. The symptomatic intradural extramedullary mass at the cervicothoracic area was removed and the histological finding was schwannoma. His leg motor weakness was relieved after surgery. At the 6-month follow-up, brain MRI revealed the progression of the vestibular schwannoma, trigeminal schwannoma, and brainstem tumor. The patient was treated with bevacizumab (5 mg/kg) every 2 weeks for 6 months. For 2 years, all of the craniospinal tumors were stable without neurological deterioration after the completion of chemotherapy. Conclusion: Meningiomas and schwannomas grow slowly in most patients with NF-2, but these multiple craniospinal tumors can show sudden rapid growth and manifest as neurological symptoms in a pediatric patient. These tumors could be controlled with local symptomatic and systemic bevacizumab treatments.
- Subjects
NEUROFIBROMATOSIS 2; CHILD patients; SCHWANNOMAS; GENETIC disorders; ACOUSTIC neuroma; HEARING disorders
- Publication
Child's Nervous System, 2022, Vol 38, Issue 11, p2205
- ISSN
0256-7040
- Publication type
Case Study
- DOI
10.1007/s00381-022-05531-6